Wogonoside induces apoptosis in Bel-7402, a hepatocellular carcinoma cell line, by regulating Bax/Bcl-2

Li,Yusheng; Tu,Min; Cheng,Chao; Tian,Jian; Zhang,Fangjie; Deng,Zhenhan; Li,Xuan'an; Li,Zhongkui; Liu,Yanping; Lei,Guanghua

doi:10.3892/ol.2015.3408

Wogonoside induces apoptosis in Bel-7402, a hepatocellular carcinoma cell line, by regulating Bax/Bcl-2

Authors:
- Yusheng Li
- Min Tu
- Chao Cheng
- Jian Tian
- Fangjie Zhang
- Zhenhan Deng
- Xuan'an Li
- Zhongkui Li
- Yanping Liu
- Guanghua Lei
View Affiliations

Affiliations: Department of Orthopaedics, Xiangya Hospital, Central South University, Changsha, Hunan 410008, P.R. China, Department of Orthopaedics, Second People's Hospital of Jingmen, Jingmen, Hubei 448000, P.R. China, Department of Cell Biology, School of Life Sciences, Central South University, Changsha, Hunan 410008, P.R. China
Published online on: June 22, 2015 https://doi.org/10.3892/ol.2015.3408
Pages: 1831-1835

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The anticancer effect of Scutellaria baicalensis extract has recently become a topic of interest. In this study, the anticancer effects and underlying mechanisms of wogonoside, the main constituent of Scutellaria baicalensis, were investigated in a human hepatocellular carcinoma (HCC) cell line in vitro. The effects of wogonoside on the proliferation, cell cycle progression and apoptosis of hepatocellular carcinoma cells were examined. Western blotting was employed to analyze the proteins associated with the biological effects of wogonoside. Wogonoside exerted anti‑proliferation properties in vitro. HCC cell growth was attenuated by wogonoside (8 µM) treatment. Cell cycle progression analysis and DNA ladder assay revealed that apoptosis was enhanced in wogonoside‑treated cells and that cell cycle arrest occurred in the G2/M phase. It was also demonstrated that increased apoptosis was accompanied by increased levels of Bax protein and decreased levels of Bcl‑2 protein. The results of this study suggest that wogonoside may represent a potential therapeutic agent against HCC.

View Figures

View References

1	Forner A, Llovet JM and Bruix J: Hepatocellular carcinoma. Lancet. 379:1245–1255. 2012. View Article : Google Scholar : PubMed/NCBI
2	Bridges JF, Joy SM, Gallego G, Kudo M, Ye SL, Han KH, Cheng AL and Blauvelt BM: Needs for hepatocellular carcinoma control policy in the Asia-Pacific region. Asian Pac J Cancer Prev. 12:2585–2591. 2011.PubMed/NCBI
3	Sherman M: Hepatocellular carcinoma: epidemiology, surveillance and diagnosis. Semin Liver Dis. 30:3–16. 2010. View Article : Google Scholar : PubMed/NCBI
4	Olsen SK, Brown RS and Siegel AB: Hepatocellular carcinoma: review of current treatment with a focus on targeted molecular therapies. Therap Adv Gastroenterol. 3:55–66. 2010. View Article : Google Scholar : PubMed/NCBI
5	EI-Serag HB: Hepatocellular carcinoma. N Engl J Med. 365:1118–1127. 2011. View Article : Google Scholar : PubMed/NCBI
6	Davila JA, Duan Z, McGlynn KA and El-Serag HB: Utilization and outcomes of palliative therapy for hepatocellular carcinoma: a population-based study in the United States. J Clin Gastroenterol. 46:71–77. 2012. View Article : Google Scholar : PubMed/NCBI
7	Riedl SJ and Salvesen GS: The apoptosome: signalling platform of cell death. Nat Rev Mol Cell Biol. 8:405–413. 2007. View Article : Google Scholar : PubMed/NCBI
8	Fabregat I, Roncero C and Fernández M: Survival and apoptosis: a dysregulated balance in liver cancer. Liver Int. 27:155–162. 2007. View Article : Google Scholar : PubMed/NCBI
9	Fransvea E, Angelotti U, Antonaci S and Giannelli G: Blocking transforming growth factor-beta up-regulates E-cadherin and reduces migration and invasion of hepatocellular carcinoma cells. Hepatology. 47:1557–1566. 2008. View Article : Google Scholar : PubMed/NCBI
10	Hussain SP, Schwank J, Staib F, Wang XW and Harris CC: TP53 mutations and hepatocellular carcinoma: insights into the etiology and pathogenesis of liver cancer. Oncogene. 26:2166–2176. 2007. View Article : Google Scholar : PubMed/NCBI
11	Normile D: Asian medicine. The new face of traditional Chinese medicine. Science. 299:188–190. 2003. View Article : Google Scholar : PubMed/NCBI
12	Yoon SB, Lee YJ, Park SK, Kim HC, Bae H, Kim HM, Ko SG, Choi HY, Oh MS and Park W: Anti-inflammatory effects of Scutellaria baicalensis water extract on LPS-activated RAW 264.7 macrophages. J Ethnopharmacol. 125:286–290. 2009. View Article : Google Scholar : PubMed/NCBI
13	Li-Weber M: New therapeutic aspects of flavones: the anticancer properties of Scutellaria and its main active constituents Wogonin, Baicalein and Baicalin. Cancer Treat Rev. 35:57–68. 2009. View Article : Google Scholar : PubMed/NCBI
14	Burnett BP, Jia Q, Zhao Y and Levy RM: A medicinal extract of Scutellaria baicalensis and Acacia catechu acts as a dual inhibitor of cyclooxygenase and 5-lipoxygenase to reduce inflammation. J Med Food. 10:442–451. 2007. View Article : Google Scholar : PubMed/NCBI
15	Zhao Q, Wang J, Zou MJ, Hu R, Zhao L, Qiang L, Rong JJ, You QD and Guo QL: Wogonin potentiates the antitumor effects of low dose 5-fluorouracil against gastric cancer through induction of apoptosis by down-regulation of NF-kappaB and regulation of its metabolism. Toxicol Lett. 197:201–210. 2010. View Article : Google Scholar : PubMed/NCBI
16	Enomoto R, Koshiba C, Suzuki C and Lee E: Wogonin potentiates the antitumor action of etoposide and ameliorates its adverse effects. Cancer Chemother Pharmacol. 67:1063–1072. 2011. View Article : Google Scholar : PubMed/NCBI
17	Li C, Lin G and Zuo Z: Pharmacological effects and pharmacokinetics properties of Radix Scutellariae and its bioactive flavones. Biopharm Drug Dispos. 32:427–445. 2011. View Article : Google Scholar : PubMed/NCBI
18	Yang YZ, Tang YZ and Liu YH: Wogonoside displays anti-inflammatory effects through modulating inflammatory mediator expression using RAW264.7 cells. J Ethnopharmacol. 148:271–276. 2013. View Article : Google Scholar : PubMed/NCBI
19	Sun Y, Zou M, Hu C, Qin Y, Song X, Lu N and Guo Q: Wogonoside induces autophagy in MDA-MB-231 cells by regulating MAPK-mTOR pathway. Food Chem Toxicol. 51:53–60. 2013. View Article : Google Scholar : PubMed/NCBI
20	Chen Y, Hui H, Yang H, Zhao K, Qin Y, Gu C, Wang X, Lu N and Guo Q: Wogonoside induces cell cycle arrest and differentiation by affecting expression and subcellular localization of PLSCR1 in AMl cells. Blood. 121:3682–3691. 2013. View Article : Google Scholar : PubMed/NCBI
21	Chen Y, Lu N, Ling Y, Gao Y, Wang L, Sun Y, Qi Q, Feng F, Liu W, Liu W, You Q and Guo Q: Wogonoside inhibits lipopolysaccharide-induced angiogenesis in vitro and in vivo via toll-like receptor 4 signal transduction. Toxicology. 259:10–17. 2009. View Article : Google Scholar : PubMed/NCBI
22	Chow SE, Chang YL, Chuang SF and Wang JS: Wogonin induced apoptosis in human nasopharyngeal carcinoma cells by targeting GSK-3β and Δ Np63. Cancer Chemother Pharmacol. 68:835–845. 2011. View Article : Google Scholar : PubMed/NCBI
23	Baumann S, Fas SC, Giaisi M, Müller WW, Merling A, Gülow K, Edler L, Krammer PH and Li-Weber M: Wogonin preferentially kills malignant lymphocytes and suppresses T-cell tumor growth by inducing PLCgamma1-and Ca2+-dependent apoptosis. Blood. 111:2354–2363. 2008. View Article : Google Scholar : PubMed/NCBI
24	Roy M, Chakraborty S, Siddiqi M and Bhattacharya RK: Induction of apoptosis in tumor cells by natural phenolic compounds. Asian Pac J Cancer Prev. 3:61–67. 2002.PubMed/NCBI
25	Dang YM, Huang G, Chen YR, Dang ZF, Chen C, Liu FL, Guo YF and Xie XD: Sulforaphane inhibits the proliferation of the BIU87 bladder cancer cell line via IGFBP-3 elevation. Asian Pac J Cancer Prev. 15:1517–1520. 2014. View Article : Google Scholar : PubMed/NCBI
26	Yu J, Liu H, Lei J, Tan W, Hu X and Zou G: Antitumor activity of chloroform fraction of Scutellaria barbata and its active constituents. Phytother Res. 21:817–822. 2007. View Article : Google Scholar : PubMed/NCBI
27	Guicciardi ME and Gores GJ: Apoptosis: a mechanism of acute and chronic liver injury. Gut. 54:1024–1033. 2005. View Article : Google Scholar : PubMed/NCBI
28	Brunelle JK and Letai A: Control of mitochondrial apoptosis by the Bcl-2 family. J Cell Sci. 122:437–441. 2009. View Article : Google Scholar : PubMed/NCBI
29	Steinbach JP and Weller M: Apoptosis in Gliomas: Molecular Mechanisms and Therapeutic Implications. J Neurooncol. 70:247–256. 2004. View Article : Google Scholar : PubMed/NCBI
30	Korsmeyer SJ: BCL-2 gene family and the regulation of programmed cell death. Cancer Res. 59:(Suppl 7). 1693–1700. 1999.
31	Chung H, Jung YM, Shin DH, Lee JY, Oh MY, Kim HJ, Jang KS, Jeon SJ, Son KH and Kong G: Anticancer effects of wogonin in both estrogen receptor-positive and -negative human breast cancer cell lines in vitro and in nude mice xenografts. Int J Cancer. 122:816–822. 2008. View Article : Google Scholar : PubMed/NCBI